ストックスクリーナーアプリを入手
0.2047
4.39%
-0.0082
前日終値:
$0.2129
開ける：
$0.21
24時間の取引高:
4.06M
Relative Volume:
0.89
時価総額：
$12.71M
収益：
$69.49M
当期純損益:
$-21.13M
株価収益率:
-0.3154
EPS:
-0.649
ネットキャッシュフロー:
$-14.46M
1週間 パフォーマンス:
-14.15%
1か月 パフォーマンス:
-19.39%
6か月 パフォーマンス:
-61.59%
1年 パフォーマンス:
-52.85%
1日の値動き範囲:
$0.2002
$0.2229
1週間の範囲:
$0.1831
$0.2755
52週間の値動き範囲:
$0.1831
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
名前
Cosmos Health Inc
セクター
電話
312-536-3102
住所
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.2047 | 13.22M | 69.49M | -21.13M | -14.46M | -0.649 |
MCK
Mckesson Corp
|
747.61 | 87.88B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
271.67 | 52.89B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
223.69 | 51.94B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
79.19 | 9.10B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.26 | 1.15B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc (COSM) 最新ニュース
Cosmos Health secures 25M unit manufacturing orderbook By Investing.com - Investing.com Canada
Cosmos Health Reports Cana Laboratories Secures Over 25 Million Units in Multi-Year Contract Manufacturing Orderbook - Quiver Quantitative
CosmoFarm's Robotic Rise: A Lifeline for Financially Strained Cosmos Health? - BriefGlance
CosmoFarm delivers record Q2 2026 revenue of over $15 million - scanx.trade
Cosmos Health Reports Record Q2 Revenue for CosmoFarm, Exceeds $60 Million Annualized Run Rate - Quiver Quantitative
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Cosmos Health Inc (COSM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Cosmos Health Inc (COSM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Cosmos Health Inc (COSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Cosmos Health enters skincare market with new product line By Investing.com - Investing.com Australia
Cosmos Health enters skincare market with new product line - Investing.com
Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States - 富途牛牛
Cosmos Health Inc (COSM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Cosmos Health Inc (COSM) Valuation: PE, PB & Fair Value Analysis - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
Cosmos Health Inc (COSM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cosmos Health signs five-year manufacturing deal with Pharmex - Investing.com
Cosmos Health signs five-year manufacturing deal with Pharmex By Investing.com - Investing.com South Africa
Cosmos HealthEnters Five-Year Contract Man - Moomoo
Cosmos Health lands five-year deal to make 2.86 million drug units - Stock Titan
Cosmos Health (COSM) CFO swaps $42K company debt for 168,135 shares - Stock Titan
$Cosmos Health (COSM.US)$ finally see a smiley face upwards movement - Moomoo
Cosmos Health Introduces Four 18 Series Products with Projected Annualized Revenue and Gross Profit in the United States - marketscreener.com
Cosmos Health Provides Update on United States Portfolio; - GlobeNewswire
Cosmos Health projects $22.7M revenue from U.S. product line - Investing.com UK
Cosmos Health projects $22.7M revenue from U.S. product line By Investing.com - Investing.com Nigeria
Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit - marketscreener.com
$Cosmos Health (COSM.US)$ just waiting to see better volume - Moomoo
Why Tower Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Cosmos Health (COSM) Secures New Contract Manufacturing Orders - GuruFocus
Cosmos Health Gets New Contract Manufacturing Orders for 253,657 Units Across Multiple Medicines - marketscreener.com
Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines - GlobeNewswire
Cosmos Health Stock (COSM) Opinions on EU Expansion and Antiseptic Sales Growth - Quiver Quantitative
Cosmos Health (NASDAQ: COSM) CEO swaps $45K company debt for shares - Stock Titan
Cosmos Health sets three-year targets for antiseptic brands By Investing.com - Investing.com Australia
Cosmos Health sets three-year targets for antiseptic brands - Investing.com
C-Scrub antiseptic tops $1.5M, aims for $7.4M across Europe - Stock Titan
Cosmos Health (NASDAQ: COSM) CEO gets 701K shares for $160K debt - Stock Titan
Cosmos Health Signs Letter of Intent to Buy Doc Pharma - Moomoo
Cosmos Health (COSM) Plans Acquisition of Doc Pharma - GuruFocus
Cosmos Health director awarded 20,000 shares | COSM Insider Trading - Stock Titan
Cosmos Health (NASDAQ: COSM) director receives 20,000-share equity award via RSU conversion - Stock Titan
Cosmos Health (NASDAQ: COSM) awards Demetriades 20K shares, now holding 55K - Stock Titan
Director at Cosmos Health (NASDAQ: COSM) awarded 40,000 shares - Stock Titan
Cosmos Health (COSM) grants 20,000 shares of stock to director - Stock Titan
Cosmos Health (NASDAQ: COSM) CFO receives 850K-share equity award via RSU conversion - Stock Titan
Cosmos Health (COSM) CEO awarded 2.35M shares via RSU conversion - Stock Titan
Cosmos Health Inc. Announces Proposed Acquisition of Doc Pharma S.A. to Enhance Vertical Integration and Product Portfolio - Quiver Quantitative
Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio - The Manila Times
Cosmos Health pursues Doc Pharma deal, adding $6.7M in sales - Stock Titan
Cosmos Health Inc (COSM) 財務データ
収益
当期純利益
現金流量
EPS
Cosmos Health Inc (COSM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
8.86%
0.00%
大文字化:
|
ボリューム (24 時間):